Mahmoud Mahmoudian is the founder of Mana Therapeutics. Mana Therapeutics has raised $35M in total funding. Latest round: Series A.
Mahmoud Mahmoudian has over 30 years of experience in biotech, focusing on venture creation, fundraising, and investment in AI-based vaccines, RNA, genetic, and precision medicines. He has held leadership roles at Cobro Ventures, Sumitomo Pharma, Merck, GlaxoSmithKline, and Ferring, contributing to 10 FDA approvals. Mahmoudian holds a PhD and MSc from Imperial College London and is a Fellow of the Royal Society.
Full founder directory · Investor directory · Company funding database · Fundraising library